According to a press release, data from an in-clinic study demonstrated that patients using the company’s MiniMed Paradigm System with Low Glucose Suspend automation experienced a 19% reduction in time spent below the low glucose threshold compared with those using conventional pump therapy.
Medtronic one step closer to Artificial Pancreas
March 1, 2012 |
Permalink
Warning: Trying to access array offset on value of type bool in /var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php on line 20
Tweet
Warning: Trying to access array offset on value of type bool in /var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php on line 20
Tweet
Posted in Artificial Pancreas